Research on COVID-19 medicine and vaccines has transformed global scientific collaboration. Rapid development and approval of vaccines using mRNA, viral vector, and protein-based platforms has reshaped how emerging diseases are managed. Ongoing studies aim to improve vaccine durability, update formulations for new variants, and reduce transmission.
Therapeutic research focuses on antiviral drugs, monoclonal antibodies, and immune-modulating treatments. Continuous surveillance and genomic monitoring allow scientists to track variants and assess treatment effectiveness. Global cooperation remains essential to prepare for future pandemics and enhance public health resilience.